The effect of a Dried Bonito Broth on the hand-foot syndrome induced by targeted molecular therapy

Not Applicable

• Conditions: Hand Foot Syndrome

• Registration Number: JPRN-jRCTs031180160
• Lead Sponsor: KAMIMURA KENYA

Brief Summary

This study revealed the effectiveness of dried bonito broth in preventing the hand-foot-syndrome caused by the molecular targeting agents for hepatocellular carcinoma. however, the study was ended since the standard therapeutic options for the advanced stage hepatocellular carcinoma has been changed from the molecular targeting agents to the immune checkpoint inhibitor.

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-02-26
• Study Completion: 2021-12-27
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 16

Inclusion Criteria

1.Patients planned to be hospitalized for administration of sorafenib or regorafenib or lenvatinib molecular therapy for HCC.
2. Patients equal or over 20 years old.

Exclusion Criteria

1. Patients who has food allergy to fish.
2. Patients who cannot eat and drink by themselves.
3. Patients who have a history of hand foot syndrome, skin disease, neurological disieases.
4. Patients for whom the physicians decided to be inappropriate candidate.

Study & Design

• Study Type: Interventional
• Study Design: Not specified